Viewing Study NCT04088032


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-02-03 @ 9:59 AM
Study NCT ID: NCT04088032
Status: WITHDRAWN
Last Update Posted: 2020-07-16
First Post: 2019-09-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer
Sponsor: Alison Stopeck
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer Female View
None Locally Advanced Breast Cancer View
None Hormone Receptor Positive Malignant Neoplasm of Breast View
Keywords: